Plasminogen Is Tethered with High Affinity to the Cell Surface by the Plasma Protein, Histidine-rich Glycoprotein*
暂无分享,去创建一个
J. Altin | M. Hulett | C. Parish | Christopher R Parish | Joseph G Altin | Allison L Jones | Mark D Hulett | Phillip Hogg | Phillip J. Hogg | Allison L. Jones
[1] Brian A. Smith,et al. Histidine-Rich Glycoprotein Binds to DNA and FcγRI and Potentiates the Ingestion of Apoptotic Cells by Macrophages1 , 2002, The Journal of Immunology.
[2] J. Altin,et al. Histidine-rich glycoprotein regulates the binding of monomeric IgG and immune complexes to monocytes. , 1999, International immunology.
[3] J. Saurat,et al. Differential protease expression by cutaneous squamous and basal cell carcinomas. , 1991, The Journal of clinical investigation.
[4] F. Blasi. Proteolysis, Cell Adhesion, Chemotaxis, and Invasiveness Are Regulated by the u-PA-u-PAR-PAI-1 System , 1999, Thrombosis and Haemostasis.
[5] W. Morgan. Interactions of the histidine-rich glycoprotein of serum with metals. , 1981, Biochemistry.
[6] V. Schirrmacher,et al. Sulfated glycosaminoglycans enhance tumor cell invasion in vitro by stimulating plasminogen activation. , 1998, Experimental cell research.
[7] K. Danø,et al. Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.
[8] H. Chapman,et al. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. , 1997, Current opinion in cell biology.
[9] J. Mimuro,et al. Histidine-rich glycoprotein and alpha 2-plasmin inhibitor in inhibition of plasminogen binding to fibrin. , 1984, Thrombosis research.
[10] J. Altin,et al. Histidine-rich glycoprotein binds to human IgG and C1q and inhibits the formation of insoluble immune complexes. , 1997, Biochemistry.
[11] F. Castellino,et al. Nonfibrinolytic functions of plasminogen. , 2000, Methods.
[12] L. Orci,et al. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes , 1990, The Journal of cell biology.
[13] S. L. Guthans,et al. The interaction of zinc, nickel and cadmium with serum albumin and histidine-rich glycoprotein assessed by equilibrium dialysis and immunoadsorbent chromatography. , 1982, Archives of biochemistry and biophysics.
[14] R. Gorodetsky,et al. Platelet multielemental composition, lability, and subcellular localization , 1993, American journal of hematology.
[15] A. Sappino,et al. Plasminogen activation in human acute leukaemias , 1999, British journal of haematology.
[16] W. T. Morgan,et al. Acceleration of Plasminogen Activation by Tissue Plasminogen Activator on Surface-bound Histidine-proline-rich Glycoprotein* , 1997, The Journal of Biological Chemistry.
[17] W. Morgan,et al. Human serum histidine-rich glycoprotein. I. Interactions with heme, metal ions and organic ligands. , 1978, Biochimica et biophysica acta.
[18] W. T. Morgan,et al. Further characterization of the interaction of histidine-rich glycoprotein with heparin: evidence for the binding of two molecules of histidine-rich glycoprotein by high molecular weight heparin and for the involvement of histidine residues in heparin binding. , 1987, Biochemistry.
[19] W. T. Morgan,et al. Histidine-Proline-rich Glycoprotein as a Plasma pH Sensor , 1998, The Journal of Biological Chemistry.
[20] J. Altin,et al. Differential Binding of Histidine-rich Glycoprotein (HRG) to Human IgG Subclasses and IgG Molecules Containing κ and λ Light Chains* , 1999, The Journal of Biological Chemistry.
[21] L. Leung. Interaction of histidine-rich glycoprotein with fibrinogen and fibrin. , 1986, The Journal of clinical investigation.
[22] N. Chang,et al. Regulation of complement functional efficiency by histidine-rich glycoprotein. , 1992, Blood.
[23] E. Davie,et al. Amino acid sequence of human histidine-rich glycoprotein derived from the nucleotide sequence of its cDNA. , 1986, Biochemistry.
[24] D. Rylatt,et al. Autorosette inhibition factor: isolation and properties of the human plasma protein. , 1981, European journal of biochemistry.
[25] M. L. Hayes,et al. Carbohydrate of the human plasminogen variants. I. Carbohydrate composition, glycopeptide isolation, and characterization. , 1979, The Journal of biological chemistry.
[26] W. T. Morgan,et al. The histidine-rich glycoprotein of serum has a domain rich in histidine, proline, and glycine that binds heme and metals. , 1985, Biochemistry.
[27] H. Chapman,et al. Macrophage fibrinolytic activity: Identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor , 1982, Cell.
[28] M. L. Hayes,et al. Carbohydrate of the human plasminogen variants. III. Structure of the O-glycosidically linked oligosaccharide unit. , 1979, The Journal of biological chemistry.
[29] P. Hogg,et al. Angiostatin Formation Involves Disulfide Bond Reduction and Proteolysis in Kringle 5 of Plasmin* , 1999, The Journal of Biological Chemistry.
[30] M. Hoylaerts,et al. Heparin binding properties of human histidine-rich glycoprotein. Mechanism and role in the neutralization of heparin in plasma. , 1983, The Journal of biological chemistry.
[31] E. Plow,et al. Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells. , 1989, Biochemistry.
[32] D. Belin,et al. The plasminogen activator/plasmin system. , 1991, The Journal of clinical investigation.
[33] J. Hoover-Plow,et al. The cell biology of the plasminogen system , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[34] K. Hajjar,et al. A mediator of cell surface-specific plasmin generation. , 2006, Annals of the New York Academy of Sciences.
[35] M. L. Hayes,et al. Carbohydrate of the human plasminogen variants. II. Structure of the asparagine-linked oligosaccharide unit. , 1979, The Journal of biological chemistry.
[36] M. Hoylaerts,et al. Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein. , 1980, The Journal of biological chemistry.
[37] M. Hulett,et al. Histidine-rich Glycoprotein Binds to Cell-surface Heparan Sulfate via Its N-terminal Domain following Zn2+ Chelation* , 2004, Journal of Biological Chemistry.
[38] W. T. Morgan,et al. Interaction of histidine-proline-rich glycoprotein with plasminogen: effect of ligands, pH, ionic strength, and chemical modification. , 1995, Biochemistry.
[39] D. Collen. Ham-Wasserman lecture: role of the plasminogen system in fibrin-homeostasis and tissue remodeling. , 2001, Hematology. American Society of Hematology. Education Program.
[40] H. Lijnen. Elements of the Fibrinolytic System , 2001, Annals of the New York Academy of Sciences.
[41] X C Zhang,et al. Molecular mechanisms of plasminogen activation: bacterial cofactors provide clues. , 2000, Trends in biochemical sciences.
[42] N. Aoki,et al. Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. , 1976, Journal of Biological Chemistry.
[43] D. Collen. The Plasminogen (Fibrinolytic) System , 1999, Thrombosis and Haemostasis.
[44] D. Walz,et al. Binding of Thrombospondin to Immobilized Ligands: Specific Interaction with Fibrinogen, Plasminogen, Histidine-Rich Glycoprotein, and Fibronectin , 1987, Seminars in thrombosis and hemostasis.
[45] K. Brown. Effect of infections on plasma zinc concentration and implications for zinc status assessment in low-income countries. , 1998, The American journal of clinical nutrition.
[46] B. Wiman. Affinity-chromatographic purification of human α2-antiplasmin , 1980 .
[47] L. Levitt,et al. Interaction of histidine-rich glycoprotein with human T lymphocytes. , 1989, The Journal of biological chemistry.
[48] W. T. Morgan,et al. Histidine-rich glycoprotein modulation of the anticoagulant activity of heparin. Evidence for a mechanism involving competition with both antithrombin and thrombin for heparin binding. , 1987, The Journal of biological chemistry.
[49] R. Ruddon. Biological markers of neoplasia : basic and applied aspects , 1978 .
[50] Timo K. Korhonen,et al. Plasminogen activation in degradation and penetration of extracellular matrices and basement membranes by invasive bacteria. , 2000, Methods.
[51] E. Rickli,et al. A new method of isolation and some properties of the heavy chain of human plasmin. , 1975, European journal of biochemistry.
[52] Jordi Félez,et al. Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. , 1991, Biochemistry.
[53] R. Hill,et al. The importance of the preactivation peptide in the two-stage mechanism of human plasminogen activation. , 1975, The Journal of biological chemistry.